HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,649,586 | -3.2% | 331,141 | -8.6% | 0.09% | -4.3% |
| Q2 2023 | $13,062,498 | -6.6% | 362,143 | -9.0% | 0.09% | -3.1% |
| Q1 2023 | $13,988,451 | -62.3% | 397,950 | -39.0% | 0.10% | -61.2% |
| Q4 2022 | $37,114,245 | +43.6% | 652,302 | -0.2% | 0.25% | +37.4% |
| Q3 2022 | $25,847,000 | +0.9% | 653,675 | +12.2% | 0.18% | -13.7% |
| Q2 2022 | $25,628,000 | -8.8% | 582,497 | -17.4% | 0.21% | +10.5% |
| Q1 2022 | $28,114,000 | -0.8% | 705,006 | -0.0% | 0.19% | +5.5% |
| Q4 2021 | $28,352,000 | -0.1% | 705,079 | +1.0% | 0.18% | -6.2% |
| Q3 2021 | $28,393,000 | +13.9% | 697,979 | +27.2% | 0.19% | +12.9% |
| Q2 2021 | $24,927,000 | -17.2% | 548,930 | -25.2% | 0.17% | -31.9% |
| Q1 2021 | $30,102,000 | -3.9% | 733,742 | -0.0% | 0.25% | +1.2% |
| Q4 2020 | $31,339,000 | +14.0% | 733,754 | -29.9% | 0.25% | -3.9% |
| Q3 2020 | $27,500,000 | +2.9% | 1,046,472 | +5.0% | 0.26% | -8.5% |
| Q2 2020 | $26,727,000 | +89.1% | 996,878 | +22.3% | 0.28% | +79.6% |
| Q1 2020 | $14,131,000 | -2.2% | 815,319 | +0.0% | 0.16% | +1.3% |
| Q4 2019 | $14,455,000 | +44.0% | 815,272 | +26.0% | 0.16% | +16.5% |
| Q3 2019 | $10,036,000 | -3.8% | 647,079 | +6.1% | 0.13% | +2.3% |
| Q2 2019 | $10,435,000 | +9.7% | 610,079 | +3.3% | 0.13% | +6.6% |
| Q1 2019 | $9,509,000 | +134.7% | 590,579 | +113.2% | 0.12% | +96.8% |
| Q4 2018 | $4,052,000 | +39.4% | 277,000 | +73.1% | 0.06% | +59.0% |
| Q3 2018 | $2,907,000 | +17.2% | 160,000 | +8.8% | 0.04% | 0.0% |
| Q2 2018 | $2,480,000 | +3.8% | 147,000 | +20.5% | 0.04% | -4.9% |
| Q1 2018 | $2,390,000 | -13.2% | 122,000 | -10.3% | 0.04% | -14.6% |
| Q4 2017 | $2,755,000 | -0.3% | 136,000 | -14.5% | 0.05% | 0.0% |
| Q3 2017 | $2,762,000 | -11.0% | 159,000 | -34.3% | 0.05% | -17.2% |
| Q2 2017 | $3,103,000 | +10.3% | 242,000 | +11.5% | 0.06% | +7.4% |
| Q1 2017 | $2,812,000 | -16.3% | 217,000 | -36.2% | 0.05% | -29.9% |
| Q4 2016 | $3,359,000 | +6.1% | 340,000 | +29.8% | 0.08% | +1.3% |
| Q3 2016 | $3,165,000 | +81.6% | 262,000 | +29.7% | 0.08% | +68.9% |
| Q2 2016 | $1,743,000 | -20.2% | 202,000 | -12.9% | 0.04% | -18.2% |
| Q1 2016 | $2,185,000 | -42.8% | 232,000 | +5.2% | 0.06% | -46.1% |
| Q4 2015 | $3,823,000 | +119.6% | 220,600 | +70.2% | 0.10% | +137.2% |
| Q3 2015 | $1,741,000 | -46.1% | 129,600 | -9.4% | 0.04% | -35.8% |
| Q2 2015 | $3,229,000 | -27.1% | 143,000 | -53.9% | 0.07% | -24.7% |
| Q1 2015 | $4,428,000 | +61.0% | 310,000 | +8.8% | 0.09% | +56.1% |
| Q4 2014 | $2,750,000 | – | 285,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |